Leveraging mRNA technology for antigen based immuno-oncology therapies

The application of messenger RNA (mRNA) technology in antigen-based immuno-oncology therapies represents a significant advancement in cancer treatment. Cancer vaccines are an effective combinatorial partner to sensitize the host immune system to the tumor and boost the efficacy of immune therapies....

Full description

Saved in:
Bibliographic Details
Main Authors: Wei Zheng, Michele Ceccarelli, Charalampos S Floudas, Siranush Sarkizova
Format: Article
Language:English
Published: BMJ Publishing Group 2025-01-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/13/1/e010569.full
Tags: Add Tag
No Tags, Be the first to tag this record!